Schroder Investment Management Group
BHVN

Schroder Investment Management Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Schroder Investment Management Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,140
Closed -$10.8M – 1353
2022
Q3 		$10.8M Buy
71,140
+2,330
+3% +$345K 0.02% 595
2022
Q2 		$10M Buy
68,810
+1,486
+2% +$190K 0.02% 651
2022
Q1 		$7.95M Buy
67,324
+22,339
+50% +$2.79M 0.01% 726
2021
Q4 		$6.2M Sell
44,985
-19,856
-31% -$2.52M 0.01% 705
2021
Q3 		$9.01M Sell
64,841
-9,374
-13% -$1.17M 0.01% 653
2021
Q2 		$7.21M Buy
74,215
+20,287
+38% +$1.65M 0.01% 752
2021
Q1 		$3.69M Buy
53,928
+9,297
+21% +$752K ﹤0.01% 887
2020
Q4 		$3.83M Sell
44,631
-6,982
-14% -$592K 0.01% 861
2020
Q3 		$3.36M Buy
51,613
+4,355
+9% +$285K 0.01% 798
2020
Q2 		$3.46M Buy
47,258
+23,248
+97% +$1.24M 0.01% 728
2020
Q1 		$770K Sell
24,010
-6,426
-21% -$294K ﹤0.01% 940
2019
Q4 		$1.66M Buy
+30,436
New +$1.51M ﹤0.01% 906

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Schroder Investment Management Group's BHVN Position: Q4 2022 in Review

Schroder Investment Management Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 71,140 shares — an estimated $10.8M sold.

Schroder Investment Management Group first reported a position in BHVN in Q4 2019 and held it in 12 quarters. The position peaked at $10.8M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Schroder Investment Management Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 71,140 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $10.8M.
  • Schroder Investment Management Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 12 quarters.
  • Schroder Investment Management Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10.8M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Schroder Investment Management Group's 13F filing for Q4 2022, filed 10 Feb 2023.